Merck & Co., Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 4, 2012 90 Pages - SKU: ICDR6792462 |
| Synopsis ICD Research's Merck & Co., Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Merck & Co., Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Merck & Co., Inc.. ICD Research's Merck & Co., Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and sells pharmaceuticals and vaccines for human and animal healthcare markets. The company manufactures pharmaceutical products in various areas such as cardiovascular, diabetes and obesity, infectious diseases, oncology, neurosciences and ophthalmology and bone, respiratory, immunology and dermatology. The company's products include prescription medicines, therapeutic and preventive agents and vaccines. The company offers its products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its products are sold across the US, Asia, Europe and Africa. Merck is headquartered in New Jersey, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

